These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17560096)

  • 21. Comparison of the intestinal absorption and bioavailability of γ-tocotrienol and α-tocopherol: in vitro, in situ and in vivo studies.
    Abuasal BS; Qosa H; Sylvester PW; Kaddoumi A
    Biopharm Drug Dispos; 2012 Jul; 33(5):246-56. PubMed ID: 22528033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cannabinoid dexanabinol is an inhibitor of the nuclear factor-kappa B (NF-kappa B).
    Jüttler E; Potrovita I; Tarabin V; Prinz S; Dong-Si T; Fink G; Schwaninger M
    Neuropharmacology; 2004 Sep; 47(4):580-92. PubMed ID: 15380375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of fatty acid patterns on the intestinal absorption pathway of quercetin in thoracic lymph duct-cannulated rats.
    Murota K; Cermak R; Terao J; Wolffram S
    Br J Nutr; 2013 Jun; 109(12):2147-53. PubMed ID: 23200408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-Monoacylglycerol Mimetic Liposomes to Promote Intestinal Lymphatic Transport for Improving Oral Bioavailability of Dihydroartemisinin.
    Zheng B; Pan F; Shi M; He C; He B; Wang R; Ren G; Yang S; Zhang S
    Int J Nanomedicine; 2024; 19():5273-5295. PubMed ID: 38859952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis.
    Achiron A; Miron S; Lavie V; Margalit R; Biegon A
    J Neuroimmunol; 2000 Jan; 102(1):26-31. PubMed ID: 10626663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of lipid vehicle and P-glycoprotein inhibition on the mesenteric lymphatic transport of paclitaxel in unconscious, lymph duct-cannulated rats.
    Cai Q; Deng X; Li Z; An D; Shen T; Zhong M
    Drug Deliv; 2016; 23(1):147-53. PubMed ID: 24786483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioavailability of seocalcitol IV: evaluation of lymphatic transport in conscious rats.
    Grove M; Nielsen JL; Pedersen GP; Müllertz A
    Pharm Res; 2006 Nov; 23(11):2681-8. PubMed ID: 17048118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of oral moxidectin bioavailability in rabbits by lipid co-administration.
    Bassissi MF; Lespine A; Alvinerie M
    Parasitol Res; 2004 Oct; 94(3):188-92. PubMed ID: 15338286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach.
    Tang TT; Hu XB; Liao DH; Liu XY; Xiang DX
    Int J Nanomedicine; 2013; 8():4415-26. PubMed ID: 24277986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation.
    Zgair A; Lee JB; Wong JCM; Taha DA; Aram J; Di Virgilio D; McArthur JW; Cheng YK; Hennig IM; Barrett DA; Fischer PM; Constantinescu CS; Gershkovich P
    Sci Rep; 2017 Nov; 7(1):14542. PubMed ID: 29109461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioavailability of lycopene in the rat: the role of intestinal lymphatic transport.
    Faisal W; O'Driscoll CM; Griffin BT
    J Pharm Pharmacol; 2010 Mar; 62(3):323-31. PubMed ID: 20487215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs.
    Dahan A; Hoffman A
    Eur J Pharm Sci; 2005 Mar; 24(4):381-8. PubMed ID: 15734305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of general anesthesia on the intestinal lymphatic transport of lipophilic drugs: comparison between anesthetized and freely moving conscious rat models.
    Dahan A; Mendelman A; Amsili S; Ezov N; Hoffman A
    Eur J Pharm Sci; 2007 Dec; 32(4-5):367-74. PubMed ID: 17980560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the impact of drug properties on the extent of intestinal lymphatic transport - in vitro and in vivo studies.
    Lawless E; Griffin BT; O'Mahony A; O'Driscoll CM
    Pharm Res; 2015 May; 32(5):1817-29. PubMed ID: 25428258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphatic transport of halofantrine in the conscious rat when administered as either the free base or the hydrochloride salt: effect of lipid class and lipid vehicle dispersion.
    Porter CJ; Charman SA; Humberstone AJ; Charman WN
    J Pharm Sci; 1996 Apr; 85(4):357-61. PubMed ID: 8901068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Water-soluble combinations of dexanabinol: prodrugs and analogs.
    Pop E
    Pharmazie; 2000 Mar; 55(3):167-71. PubMed ID: 10756534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphatic transport of puerarin occurs after oral administration of different lipid-based formulations to unconscious lymph duct-cannulated rats.
    Zhou A; Lu T; Wang L; Lu C; Wang L; Wan M; Wu H
    Pharm Dev Technol; 2014 Sep; 19(6):743-7. PubMed ID: 23978005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microemulsions containing long-chain oil ethyl oleate improve the oral bioavailability of piroxicam by increasing drug solubility and lymphatic transportation simultaneously.
    Xing Q; Song J; You X; Xu D; Wang K; Song J; Guo Q; Li P; Wu C; Hu H
    Int J Pharm; 2016 Sep; 511(2):709-18. PubMed ID: 27473280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model.
    Griffin BT; O'Driscoll CM
    J Pharm Pharmacol; 2006 Jul; 58(7):917-25. PubMed ID: 16805951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triglyceride-mimetic prodrugs of scutellarin enhance oral bioavailability by promoting intestinal lymphatic transport and avoiding first-pass metabolism.
    Wang X; Zhang C; Han N; Luo J; Zhang S; Wang C; Jia Z; Du S
    Drug Deliv; 2021 Dec; 28(1):1664-1672. PubMed ID: 34338567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.